The Protective Effect of Prostaglandin on Coronary Microcirculation and Ventricular Remodeling After Reperfusion Therapy in Acute ST-segment Elevation Myocardial Infarction
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 220 participants.
Also called NCT05043558
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 220 participants
- Sponsor
- Shenzhen People's Hospital
- Registry
-
NCT05043558
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05043558. Randomized; single masking; primary purpose treatment. Start 2022-01-01 (anticipated); primary completion 2022-01-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Protective Effect of Prostaglandin on Coronary Microcirculation and Ventricular Remodeling After Reperfusion Therapy in Acute ST-segment Elevation Myocardial Infarction
- Condition
- STEMI
- Intervention (Drug)
- beprostaglandin sodium
- Lead sponsor
- Shenzhen People's Hospital
Record details
- Record id
cardio:ct-nct05043558- Content hash
ce755c9ecabaa059556f83c4a08f991f7a66e711e5688cc5ada9b837eef47bff